Literature DB >> 17432702

Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury.

Amy K Wagner1, Dianxu Ren, Yvette P Conley, Xiecheng Ma, Mary E Kerr, Ross D Zafonte, Ava M Puccio, Donald W Marion, C Edward Dixon.   

Abstract

OBJECT: Dopamine (DA) pathways have been implicated in cognitive deficits after traumatic brain injury (TBI). Both sex and the dopamine transporter (DAT) 3' variable number of tandem repeat polymorphism have been associated with differences in DAT protein density, and DAT protein affects both presynaptic DA release, through reverse transport, and DA reuptake. Catecholamines and associated metabolites are subject to autooxidation, resulting in the formation of reactive oxygen species that may contribute to subsequent oxidative injury. The purpose of this study was to determine associations between factors that affect DAT expression and cerebrospinal fluid (CSF) DA and metabolite levels after severe TBI.
METHODS: Sixty-three patients with severe TBI (Glasgow Coma Scale score < or = 8) were evaluated. The patients' genotypes were obtained using previously banked samples of CSF, and serial CSF samples (416 samples) were used to evaluate DA and metabolite levels. High-performance liquid chromatography was used to determine CSF levels of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) during the first 5 days after injury. Mixed-effects multivariate regression modeling revealed that patients with the DAT 10/10 genotype had higher CSF DA levels than patients with either the DAT 9/9 or DAT 9/10 genotypes (p = 0.009). Females with the DAT 10/10 genotype had higher CSF DA levels than females with the DAT 9/9 or DAT 9/10 genotypes, and sex was associated with higher DOPAC levels (p = 0.004). Inotrope administration also contributed to higher DA levels (p = 0.002).
CONCLUSIONS: In addition to systemic administration of DA, inherent factors such as sex and DAT genotype affect post-TBI CSF DA and DA metabolite levels, a phenomenon that may modulate susceptibility to DA-mediated oxidative injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17432702     DOI: 10.3171/jns.2007.106.4.538

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

Review 1.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

2.  Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes.

Authors:  Michelle D Failla; John M Myrga; Joseph H Ricker; C Edward Dixon; Yvette P Conley; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2015 Nov-Dec       Impact factor: 2.710

3.  A Rehabilomics framework for personalized and translational rehabilitation research and care for individuals with disabilities: Perspectives and considerations for spinal cord injury.

Authors:  Amy K Wagner
Journal:  J Spinal Cord Med       Date:  2014-07-16       Impact factor: 1.985

Review 4.  Genetics and outcomes after traumatic brain injury (TBI): what do we know about pediatric TBI?

Authors:  Brad Kurowski; Lisa J Martin; Shari L Wade
Journal:  J Pediatr Rehabil Med       Date:  2012

5.  A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice.

Authors:  S Edut; V Rubovitch; M Rehavi; S Schreiber; C G Pick
Journal:  J Mol Neurosci       Date:  2014-08-16       Impact factor: 3.444

6.  The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI.

Authors:  Amy K Wagner; Joelle M Scanlon; Carl R Becker; Anne C Ritter; Christian Niyonkuru; Clifton E Dixon; Yvette P Conley; Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-21       Impact factor: 6.200

Review 7.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

8.  Influence of Dopamine-Related Genes on Neurobehavioral Recovery after Traumatic Brain Injury during Early Childhood.

Authors:  Amery Treble-Barna; Shari L Wade; Lisa J Martin; Valentina Pilipenko; Keith Owen Yeates; H Gerry Taylor; Brad G Kurowski
Journal:  J Neurotrauma       Date:  2017-03-21       Impact factor: 5.269

9.  Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know.

Authors:  Raeesa Gupte; William Brooks; Rachel Vukas; Janet Pierce; Janna Harris
Journal:  J Neurotrauma       Date:  2019-07-19       Impact factor: 5.269

10.  Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission.

Authors:  Amy K Wagner; Joshua E Sokoloski; Xiangbai Chen; Rashed Harun; Damian P Clossin; Amina S Khan; Meghan Andes-Koback; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2009-05-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.